NAMSNewAmsterdam Pharma Company N.V.
What is the market doing?
The market is leaning against it: in a downtrend (−35% vs 200-day) and a crowded short (+16% of shares).
In a downtrend, below its 50- and 200-day averages. Price is −35% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
A crowded short, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How NAMS is trading
NewAmsterdam Pharma Company N.V. is −46% over the past year while the S&P 500 is +16%: 62 points behind the market. Through the fall, its own insiders bought $186K more stock than they sold.
1-year return · S&P 500 +16%
- vs 200-day average
- −35%
vs 200-day average · a clear downtrend
- RSI (14)
- 32
RSI (14) · neutral
- Below its 52-week high
- 52%
Below its 52-week high
Details›
- Last close2026-10-23
- $19.70
- 1 monthS&P 500 −0.94%
- −13%
- 1 yearS&P 500 +16%
- −46%
- 5 yearsS&P 500 +86%
- +101%
- vs 50-day average$23.57
- −16%
- 52-week high
- $41.45
- 52-week low
- $19.70
- Annualised volatility
- 64%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-22
- $186K
| Year | Return |
|---|---|
| 2026 (year to date) | −44% |
| 2025 | +36% |
| 2024 | +130% |
| 2023 | +2.5% |
| 2022 | +12% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | +16% |
| Feb | 5 | 2 of 5 | +3.7% |
| Mar | 6 | 3 of 6 | −1.7% |
| Apr | 6 | 2 of 6 | −2.9% |
| May | 6 | 1 of 6 | −1.1% |
| Jun | 6 | 4 of 6 | −1.7% |
| Jul | 6 | 2 of 6 | −1.9% |
| Aug | 6 | 2 of 6 | −2.3% |
| Sep | 6 | 4 of 6 | +1.2% |
| Oct | 6 | 3 of 6 | +2.4% |
| Nov | 5 | 3 of 5 | +2.9% |
| Dec | 5 | 3 of 5 | +13% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.